Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Diversifying editorial boards to mitigate the global burden of genitourinary cancers

Nature Reviews Urology (2024)Cite this article

Subjects

The growing global burden of genitourinary cancers is disproportionately shouldered by low- and middle-income countries. Medical journals offer an avenue for discourse among different stakeholders to strategize and identify solutions. Thus, achieving diversity in this context is crucial to put together a heterogeneous group of stakeholders with diverse personal and cultural experiences as well as distinct problem-solving approaches.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Tian, Y.-Q. et al. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: systematic analysis for the Global Burden of Disease Study 2019. Front. Public Health 11, 1119374 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Van Hemelrijck, M. The burden of urological cancers in low- and middle-income countries. BJU Int. 123, 557 (2019).

    Article  PubMed  Google Scholar 

  3. Brand, N. R., Qu, L. G., Chao, A. & Ilbawi, A. M. Delays and barriers to cancer care in low‐ and middle‐income countries: a systematic review. Oncologist 24, e1371–e1380 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rock, D. & Grant, H. Why diverse teams are smarter. Harv. Bus. Rev. https://hbr.org/2016/11/why-diverse-teams-are-smarter (2016).

  5. Hewlett, S. A., Marshall, M. & Sherbin, L. How diversity can drive innovation. Harv. Bus. Rev. https://hbr.org/2013/12/how-diversity-can-drive-innovation (2013).

  6. Dai, N., Li, J., Ren, L. & Bu, Z. Gender representation on editorial boards of leading oncology journals. ESMO Open 7, 100590 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Arter, Z., Mar, N., Rezazadeh, A. & Benjamin, D. J. Diversity among editorial boards of genitourinary oncology journals. J. Clin. Oncol. 42 (Suppl. 4), 481 (2024).

    Article  Google Scholar 

  8. Bransch, F. & Kvasnicka, M. Male gatekeepers: gender bias in the publishing process? J. Econ. Behav. Organ. 202, 714–732 (2022).

    Article  Google Scholar 

  9. Goyanes, M. & Demeter, M. How the geographic diversity of editorial boards affects what is published in JCR-ranked communication journals. Journal. Mass. Commun. Q. 97, 1123–1148 (2020).

    Article  Google Scholar 

  10. Cardone, C. & Arnold, D. The cancer treatment gap in lower- to middle-income countries. Oncology. 101 (Suppl. 1), 2–4 (2023).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hoag Family Cancer Institute, Newport Beach, CA, USA

    David J. Benjamin

  2. Division of Hematology/Oncology, Department of Medicine, UC Irvine Medical Center, Orange, CA, USA

    Zhaohui Arter, Nataliya Mar & Arash Rezazadeh Kalebasty

Authors
  1. David J. Benjamin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaohui Arter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nataliya Mar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arash Rezazadeh Kalebasty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Benjamin.

Ethics declarations

Competing interests

D.J.B. declares consulting or advisory role at Seagen, Astellas and Eisai; speakers’ bureau at Merck; and travel and accommodations from Merck. N.M. declares speakers’ bureau at Seagen, Aveo, Eisai, Tempus and Merck, and research funding from Gilead Sciences. A.R.K. declares stock and other ownership interests from ECOM Medical; consulting or advisory role from Exelixis, AstraZeneca, Bayer, Pfizer, Novartis, Genentech, Bristol Myers Squibb, EMD Serono, Immunomedics and Gilead Sciences; speakers’ bureau at Janssen, Astellas Medivation, Pfizer, Novartis, Sanofi, Genentech/Roche, Eisai, AstraZeneca, Bristol Myers Squibb, Amgen, Exelixis, EMD Serono, Merck, Seattle Genetics/Astellas, Myovant Sciences, Gilead Sciences and AVEO; research funding from Genentech, Exelixis, Janssen, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Macrogenics, Astellas Pharma, BeyondSpring Pharmaceuticals, BioClin Therapeutics, Clovis Oncology, Bavarian Nordic, Seattle Genetics, Immunomedics and Epizyme; and travel, accommodations and expenses from Genentech, Prometheus, Astellas Medivation, Janssen, Eisai, Bayer, Pfizer, Novartis, Exelixis and AstraZeneca. Z.A. declares no competing interests.

Additional information

Related links

ASCO journals editorial fellowship: https://ascopubs.org/fellowship

ASCO virtual mentoring program: https://old-prod.asco.org/career-development/mentorship/virtual-mentoring-program

ESMO virtual mentorship program: https://www.esmo.org/career-development/young-oncologists-corner/about-young-oncologists-corner/esmo-virtual-mentorship-programme

Nature Research Editing Service: https://authorservices.springernature.com

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benjamin, D.J., Arter, Z., Mar, N. et al. Diversifying editorial boards to mitigate the global burden of genitourinary cancers. Nat Rev Urol (2024). https://doi.org/10.1038/s41585-024-00867-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41585-024-00867-x

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer